Highlights
- Sanofi Consumer Healthcare India shares surged 15.31% to ₹4,662.90, adding ₹613.70 in a single session on 23 February 2026.
- Q3 FY26 Revenue jumped to ₹251 crore, representing a robust 46.8% year-on-year increase from ₹171 crore.
- Net Profit witnessed significant growth, rising to ₹66 crore compared to ₹44 crore in the previous year's corresponding quarter.
- Technical Support & Resistance: Immediate technical support is identified at ₹4,000–4,200, while the stock faces resistance at ₹4,700–4,800.
Sanofi Consumer Healthcare India Ltd (NSE:SANOFICONR) gained 15.31%, rising ₹613.70 to ₹4,662.90. The magnitude of the move suggests institutional accumulation rather than purely retail-driven momentum.
Financial Overview
In Q3 FY26 (Dec 2025), the company reported strong revenue growth, with sales rising to ₹251 crore from ₹171 crore in Q3 FY25, marking a 46.8% year-on-year increase. Operating profit improved to ₹90 crore, up from ₹62 crore, while OPM remained stable at 36%. Net profit increased to ₹66 crore versus ₹44 crore in the same period last year, reflecting both top-line expansion and efficient cost management. EPS rose to ₹28.87 from ₹19.24. The results highlight robust operational performance and profitability, underpinned by sustained demand and disciplined expense control.
Growth Catalysts
- Expansion of OTC product portfolio
• Distribution network strengthening
• Premium brand positioning
• Defensive earnings demand in volatile markets
Consumer healthcare remains a structurally resilient sector.
Technical Outlook
Support: ₹4,000–4,200
Resistance: ₹4,700–4,800
Sustained move above ₹4,700 could signal continuation of bullish trend.
Risks
- Regulatory pricing pressure
• Competitive intensity in OTC segment
• Raw material cost inflation
• Slower-than-expected volume growth
Frequently Asked Questions (FAQs)
1.What triggered the 15.31% rise in Sanofi Consumer Healthcare shares today?
The surge followed the release of stellar Q3 FY26 results, featuring a 46.8% jump in sales and a substantial increase in net profit to ₹66 crore. The volume of the move suggests strong institutional interest.
- How did the company's profitability margins perform in Q3 FY26?
The company maintained a highly efficient Operating Profit Margin (OPM) of 36%. This stability, combined with top-line growth, allowed operating profit to scale from ₹62 crore to ₹90 crore year-on-year.
- What are the key technical levels for SANOFICONR stock?
Currently, the stock has established a support base at ₹4,000–4,200. A sustained move above the ₹4,700–4,800 resistance zone could signal a continuation of the current bullish trend.